Article

Distinct druggable biological processes in early-onset prostate cancer

2025-04-29

Abstract excerpt

Despite advances in understanding and treating Prostate Cancer (PCa), there has been little effort to systematically map the biology distinguishing Early-(EOPCa) and Late-(LOPCa) onset PCa. Around 25% of EOPCa cases present with metastatic spread or aggressive disease with earlier metastatic development. Some available lines of therapy are extending treatment trajectories and prolonging lives. However, there remai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c9b8598d-5c5c-5082-ba98-e54135091856
DOI: 10.1101/2025.04.25.650707

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Distinct druggable biological processes in early-onset prostate cancerDOI 10.1101/2025.04.25.650707Read

Human Prostate Cancer Hallmarks MapSemantic proximity Read

Identifying patients with rapid progression from hormone-sensitive to castration-resistant prostate cancer: a retrospective studySemantic proximity Read

Integrative multi-omics and drug–response characterization of patient-derived prostate cancer primary cellsSemantic proximity Read

Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glanceSemantic proximity Read

Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets.Semantic proximity Read

De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment?Semantic proximity Read

Key Points in Prostate Cancer DiagnosisSemantic proximity Read

Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancerSemantic proximity Read

Unravelling the molecular mechanisms of prostate cancer evolution from genotype to phenotype.Semantic proximity Read

De Novo Metastatic Prostate Cancer: Are We Moving towards a Personalized Treatment?Semantic proximity Read

Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics ApproachSemantic proximity Read

Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical TrajectoriesSemantic proximity Read